Atlas Trials

The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients

Clinical trial NCT00336115 · UNKNOWN

Trial details

NCT number
NCT00336115
Sponsor
Queen Elizabeth II Health Sciences Centre
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Pertussis
Start date
2006-07-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.